Harmonized data and biomarkers from MORGAM Study
Harmonized MORGAM data, including biomarkers. NOTE: Variables are renamed to have prefix "MG_" in this harmonized dataset.
For access to the harmonized MORGAM data from many MORGAM Centres, one should seek a collaboration with any of the Centre which can submit a publication proposal to the MORGAM/BiomarCaRE Steering Group.
Population
MORGAM cohorts
Cohorts of the studies in the [MORGAM Network](https://mica.eucanshare.bsc.es/network/morgam).
MORGAM cohorts
Cohorts of the studies in the [MORGAM Network](https://mica.eucanshare.bsc.es/network/morgam).
Files
| # | Name | Description | Size | Actions |
|---|---|---|---|---|
No files could be found.
Studies Included
Individual Studies
| Study | Population | Data Collection Event | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATBC |
ATBC Study CohortThe cohort was recruited to the ATBC Study, a clinical trial for cancer prevention, and it consist of male smokers aged 50-69 years. The participants of the initial survey were invited to re-examinations.
The cohort is identified by Cohort number 31 of the FIN-ATB in MORGAM data. See the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-atba.htm). A case-cohort set (selection 20) was sampled from a subset of the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ATBC Study Baseline
Baseline examination during which participants completed a general risk factor, smoking, and medical history questionnaire, along with a food frequency questionnaire (FFQ).
Background factors, lifestyle, anthropometric measures, medical history were recorded.
Fasting serum samples were collected. Toenail sample was also collected (Nail samples are stored in National Cancer Institute, USA).
Genome-wide SNP data is available for selection of the study participants (imputed genotype data and chip genotypes).
This data collection event is identified by round number 01 of the FIN-ATB Cohort 21 in the harmonized MORGAM data. Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection in the MORGAM Project.
For the data available locally (registries, nutrition, genomics (for a subgroup), please see the website of THL Biobank where the variables are described in detail. The ATBC Study Web Site describes the study details and procedures used for data collection and the questionnaire forms used are available for download.
|
||||||||||
| ATBC |
ATBC Study CohortThe cohort was recruited to the ATBC Study, a clinical trial for cancer prevention, and it consist of male smokers aged 50-69 years. The participants of the initial survey were invited to re-examinations.
The cohort is identified by Cohort number 31 of the FIN-ATB in MORGAM data. See the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-atba.htm). A case-cohort set (selection 20) was sampled from a subset of the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ATBC Study Round 2
Re-examinations of the cohort consisted of three annual visits to the local field center. Round 2 denotes the time of the intermediate serum sampling in a random sample of the cohort in the MORGAM data.
Participants were asked about their health, use of non-trial vitamin supplements, and smoking habits since the last visit.
Height, weight, blood pressure, heart rate, and visual acuity were measured once a year. At three years, the food frequency questionnaire was repeated for all participants.
Fasting serum samples were collected. From the second year of the study onward, serum was also taken annually from a random sample of 700-800 participants.
For the data available locally (registries, nutrition, genomics (for a subgroup), please see the website of THL Biobank where the variables are described in detail. The ATBC Study Web Site describes the study details and procedures used for data collection and the questionnaire forms used are available for download.
|
||||||||||
| ATBC |
ATBC Study CohortThe cohort was recruited to the ATBC Study, a clinical trial for cancer prevention, and it consist of male smokers aged 50-69 years. The participants of the initial survey were invited to re-examinations.
The cohort is identified by Cohort number 31 of the FIN-ATB in MORGAM data. See the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-atba.htm). A case-cohort set (selection 20) was sampled from a subset of the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ATBC Study Round 3
Re-examinations of the cohort consisted of three annual visits to the local field center. Round 3 denotes the time of whole blood sampling in the MORGAM data.
Participants were asked about their health, use of non-trial vitamin supplements, and smoking habits since the last visit.
Height, weight, blood pressure, heart rate, and visual acuity were measured once a year. At three years, the food frequency questionnaire was repeated for all participants.
A whole-blood sample was obtained for germline DNA. From the second year of the study onward, serum was also taken annually from a random sample of 700-800 participants.
For the data available locally (registries, nutrition, genomics (for a subgroup), please see the website of THL Biobank where the variables are described in detail. The ATBC Study Web Site describes the study details and procedures used for data collection and the questionnaire forms used are available for download.
|
||||||||||
| ATBC |
ATBC Study CohortThe cohort was recruited to the ATBC Study, a clinical trial for cancer prevention, and it consist of male smokers aged 50-69 years. The participants of the initial survey were invited to re-examinations.
The cohort is identified by Cohort number 31 of the FIN-ATB in MORGAM data. See the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-atba.htm). A case-cohort set (selection 20) was sampled from a subset of the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ATBC Study Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see more in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-atba.htm).
For the data available locally (registries, nutrition, genomics (for a subgroup), please see the website of THL Biobank where the variables are described in detail. The data of national health registers (e.g., mortality, cancer, health care and medicines) are available by request through the Findata-process.
The ATBC Study Web Site describes the study details and procedures used for data collection and the questionnaire forms used are available for download.
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the ITA-BRI in MORGAM data. See the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in the MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza MONICA Study Cohort 01 Baseline
Baseline examination (questionnaire and health examination).
Biomarkers have been measured in BiomarCaRE Project.
Genomics, transcriptomics and metabolomics data are available on a nested, case-cohort substudy. Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection.
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the ITA-BRI in MORGAM data. See the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in the MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza MONICA Study Cohort 01 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-bria.htm).
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the ITA-BRI in MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza MONICA Study Cohort 02 Baseline
Baseline examination (questionnaire and health examination).
Biomarkers have been measured in BiomarCaRE Project.
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection. Genomics, transcriptomics and metabolomics data are available on a nested, case-cohort substudy.
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the ITA-BRI in MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza Study Cohort 02 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-bria.htm).
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the ITA-BRI in MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza MONICA Study Cohort 03 Baseline
Baseline examination (questionnaire and health examination).
Biomarkers have been measured in BiomarCaRE Project.
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection. Genomics, transcriptomics and metabolomics data are available on a nested, case-cohort substudy.
|
||||||||||
| Brianza |
Brianza MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the ITA-BRI in MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 43) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris or stroke. Persons with history of myocardial infarction or stroke were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 22) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Brianza MONICA Study Cohort 03 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-bria.htm).
|
||||||||||
| Catalonia |
Catalonia MONICA Study Cohort 01The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project. The cohort members were re-contacted for direct interview and re-examination ten years after the baseline survey.
The cohort is identified by Cohort number 01 of the SPA-CAT in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Catalonia MONCA Study Cohort 01 Baseline
Baseline examination (questionnaire and health examination)
This baseline data is identified by Round number 01 of the Cohort 01 (SPA-CAT) in the harmonized MORGAM data. Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| Catalonia |
Catalonia MONICA Study Cohort 01The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project. The cohort members were re-contacted for direct interview and re-examination ten years after the baseline survey.
The cohort is identified by Cohort number 01 of the SPA-CAT in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Catalonia MONICA Study Cohort 01 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonozed MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/spain/spa-cata.htm). Follow-up the non-fatal events ends at the date when the person was last contacted or linked with the MI register, whichever date was later.
|
||||||||||
| Catalonia |
Catalonia MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort members were re-contacted for direct interview and re-examination eight years after the baseline survey.
The cohort is identified by Cohort number 02 of the SPA-CAT in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Catalonia MONICA Study Cohort 02 Baseline
Baseline examination (questionnaire and health examination)
This baseline data is identified by Round number 01 of the Cohort 02 (SPA-CAT) in the harmonized MORGAM data, Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| Catalonia |
Catalonia MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort members were re-contacted for direct interview and re-examination eight years after the baseline survey.
The cohort is identified by Cohort number 02 of the SPA-CAT in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Catalonia MONICA Study Cohort 02 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/spain/spa-cata.htm). Follow-up for the non-fatal events ends at the date when the person was last contacted or linked with the MI register, whichever date was later.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort has two re-examination rounds after the baseline. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination)
This baseline data is identified by Round number 01 of the Cohort 01 (DEN-GLO) in the harmonized MORGAM data. Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort has two re-examination rounds after the baseline. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 01 Round 02
First re-examination (questionnaire and health examination) of the cohort.
This re-examination data is identified by Round number 02 of the Cohort 01 (DEN-GLO) in the harmonized MORGAM data. Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort has two re-examination rounds after the baseline. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 01 Round 03
Second re-examination (questionnaire and health examination) of the cohort.
This re-examination data is identified by Round number 03 of the Cohort 01 (DEN-GLO) in the harmonized MORGAM data.Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort has two re-examination rounds after the baseline. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 01 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/denmark/den-gloa.htm).
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 02 of the DEN-GLO in the MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination)
Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 02 of the DEN-GLO in the MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 02 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/denmark/den-gloa.htm).
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination)
Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| DAN-MONICA |
DAN-MONICA Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 01 of the DEN-GLO in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 58) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
DAN-MONICA Cohort 03 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/denmark/den-gloa.htm).
|
||||||||||
| ESTHER |
ESTHER CohortThe cohort consists of the participants recruited at their general practitioner's office while doing a health check-up. A general health screening examination is offered every two years for people older than 35 years in Germany.
The cohort is identified by Cohort number 21 GER-ESR in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-esra.htm). Re-examinations are not available in MORGAM.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ESTHER Study baseline
Baseline examination (questionnaire and health examination). Information was collected from a self-administered questionnaire for the study participants about previously diagnosed medical conditions diagnosed by a doctor, eating habits, alcohol consumption, smoking, occupational stress, family predisposition, health-related quality of life and social environment.
Also, comprehensive medical data collection including results of physical assessment, medical diagnoses, and drug prescriptions were obtained from the general practitioner.
Blood, urine and stool samples were collected.
Baseline is the only data collection event available in the MORGAM and it is identified by the round 01 of the Cohort 21 of the GER-ESR in the MORGAM data.
|
||||||||||
| ESTHER |
ESTHER CohortThe cohort consists of the participants recruited at their general practitioner's office while doing a health check-up. A general health screening examination is offered every two years for people older than 35 years in Germany.
The cohort is identified by Cohort number 21 GER-ESR in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-esra.htm). Re-examinations are not available in MORGAM.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
ESTHER Study Mortality and disease outcome follow-up in MORGAM data
The follow-up for deaths, cardiovascular events, type 2 diabetes and cancers are harmonized the MORGAM (up to follow-up round 4, taking into account all rounds 2-4), see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-esra.htm).
|
||||||||||
| FINRISK |
FINRISK Survey 1982The cohort consists of the participants of representative population survey carried out in the FINRISK 1982 Survey that was as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK1982 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. The questionnaire forms used in the survey are available for download in the webpage of the THL (in Finnish). The description of the FINRISK 1982 study and the local variables available are described in the Finnish Data Resources catalogue (mainly in Finnish).
|
||||||||||
| FINRISK |
FINRISK Survey 1982The cohort consists of the participants of representative population survey carried out in the FINRISK 1982 Survey that was as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1982 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
|
||||||||||
| FINRISK |
FINRISK Survey 1987The cohort consists of the participants of representative population survey carried out in the national FINRISK 1987 Survey that was a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1987 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. The questionnaire forms used in the survey are available for download in the webpage of the THL (in Finnish). The description of the FINRISK 1987 study and the local variables available are described in the Finnish Data Resources catalogue (mainly in Finnish).
|
||||||||||
| FINRISK |
FINRISK Survey 1987The cohort consists of the participants of representative population survey carried out in the national FINRISK 1987 Survey that was a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1987 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
|
||||||||||
| FINRISK |
FINRISK Survey 1992The cohort consists of the participants of representative population survey carried out in the national FINRISK 1992 Survey that was a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 37) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1992 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection in the MORGAM Project. For the data available locally, please see the webpage of the THL Biobank where the local variables are described in detail. The questionnaire forms used in the survey are available for download in the webpage of the THL (in Finnish). The description of the FINRISK 1992 study and the local variables available are also described in the Finnish Data Resources Catalogue (mainly in Finnish).
|
||||||||||
| FINRISK |
FINRISK Survey 1992The cohort consists of the participants of representative population survey carried out in the national FINRISK 1992 Survey that was a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the FIN-EAS/WES in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 37) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1992 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
For the data available locally (registries, nutrition, genomics, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/the-national-finrisk-study-1992-2012) where the variables are listed in detail. The data of national health registers (e.g., mortality, cancer, health care and medicines) are available by request through the Findata-process.
|
||||||||||
| FINRISK |
FINRISK Survey 1997The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 1997.
The cohort is identified by Cohort number 24 of the FIN-EAS/WES in the harmonized MORGAM data (and also round 04 of Cohort 01, round 03 of Cohort 02, and round 02 of Cohort 03). See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 57) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 38) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1997 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. The baseline data for the participants in 1997 are identified by Round 04 of the Cohort 01, Round 03 of the Cohort 02, Round 02 of the Cohort 03 and Round 01 of the Cohort 24 (FIN-EAS/WES) in the harmonized MORGAM data. Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project. Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection. For the data available locally, please see the webpage of the THL Biobank where the local variables are described in detail. The questionnaire forms used in the survey are available for download in the webpage of the THL. The description of the FINRISK 1997 study and the local variables available are described also in the Finnish Data Resources Catalogue (mainly in Finnish).
|
||||||||||
| FINRISK |
FINRISK Survey 1997The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 1997.
The cohort is identified by Cohort number 24 of the FIN-EAS/WES in the harmonized MORGAM data (and also round 04 of Cohort 01, round 03 of Cohort 02, and round 02 of Cohort 03). See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 57) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 38) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 1997 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
For the data available locally (registries, nutrition, genomics, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/the-national-finrisk-study-1992-2012) where the variables are listed in more detail. The data of national health registers (e.g., mortality, cancer, health care and medicines) are available by request through the Findata-process.
|
||||||||||
| FINRISK |
FINRISK Survey 2002The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 2002. The cohort is identified by Cohort number 25 of the FIN-EAS/WES in the harmonized MORGAM data (and also few people in round 05 of Cohort 01, round 04 of Cohort 02, round 03 of Cohort 03, and round 02 of Cohort 24). See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 2002 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. For the data available locally, please see thewebpage of the THL Biobank where the local variables are described in detail. The questionnaire forms used in the survey are available for download in the webpage of the THL. The description of the FINRISK 2002 study and the local variables available are described in the Finnish Data Resources Catalogue (mainly in Finnish). The baseline data for the participants in 2002 are identified by Round 05 of the Cohort 01, Round 04 of the Cohort 02, Round 03 of the Cohort 03, Round 02 of the Cohort 24 and Round 01 of the Cohort 25 (FIN-EAS/WES) in the harmonized MORGAM data.
|
||||||||||
| FINRISK |
FINRISK Survey 2002The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 2002. The cohort is identified by Cohort number 25 of the FIN-EAS/WES in the harmonized MORGAM data (and also few people in round 05 of Cohort 01, round 04 of Cohort 02, round 03 of Cohort 03, and round 02 of Cohort 24). See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 2002 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
For the data available locally (registries, nutrition, genomics, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/the-national-finrisk-study-1992-2012) where the variables are listed in more detail. The data of national health registers (e.g., mortality, cancer, health care and medicines) are available by request through the Findata-process.
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study Cohort 01 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for the harmonized MORGAM data, see the end-points followed up in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study Cohort 02 baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study Cohort 02 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study Cohort 03 baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Friuli |
Friuli MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Study Cohort 03 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
|
||||||||||
| Friuli |
Friuli MONICA Optional Study CohortThe cohort consists of the participants of a representative population survey carried out as a part of the MONICA Optional Study on Haemostatic Factors.
The cohort is identified by Cohort number 21 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Optional Study baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Friuli |
Friuli MONICA Optional Study CohortThe cohort consists of the participants of a representative population survey carried out as a part of the MONICA Optional Study on Haemostatic Factors.
The cohort is identified by Cohort number 21 of the ITA-FRI in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Friuli MONICA Optional Study mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-fria.htm).
|
||||||||||
| KORA |
KORA Survey S1The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the GER-AUG in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm). A case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S1 Baseline
Baseline examination (questionnaire and health examination). Information on sociodemographic variables, risk factors (smoking, alcohol consumption, physical activity, etc.), medical history and family history of chronic diseases, medication use, and more was gathered by trained medical staff during an extensive standardized face to face interview.
In addition, all participants underwent a standardized medical examination including blood pressure measurements and anthropometric measurements.
Biosamples were collected.
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection in the MORGAM Project.
|
||||||||||
| KORA |
KORA Survey S1The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the GER-AUG in the MORGAM data, see the detailed cohort description in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm). A case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S1 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm).
The end of follow-up depends on when the person returned the follow-up questionnaire or when population registries gave information on vital status and address.
|
||||||||||
| KORA |
KORA Survey S2The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the GER-AUG in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S2 Baseline
Baseline examination (questionnaire and health examination). Information on sociodemographic variables, risk factors (smoking, alcohol consumption, physical activity, etc.), medical history and family history of chronic diseases, medication use, and more was gathered by trained medical staff during an extensive standardized face to face interview.
In addition, all participants underwent a standardized medical examination including blood pressure measurements and anthropometric measurements.
Blood samples were collected.
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection in the MORGAM Project.
|
||||||||||
| KORA |
KORA Survey S2The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the GER-AUG in the MORGAM data, see the detailed cohort description in MORGAM e-publication. A case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S2 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm).
The end of follow-up depends on when the person returned the follow-up questionnaire or when population registries gave information on vital status and address.
|
||||||||||
| KORA |
KORA Survey S3The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort numbers 03 and 33 of the GER-AUG in the MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 55) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke or type 2 diabetes. Persons with history of myocardial infarction, stroke or hearth failure were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S3 Baseline
Baseline examination (questionnaire and health examination). Information on sociodemographic variables, risk factors (smoking, alcohol consumption, physical activity, etc.), medical history and family history of chronic diseases, medication use, and more was gathered by trained medical staff during an extensive standardized face to face interview.
In addition, all participants underwent a standardized medical examination including blood pressure measurements and anthropometric measurements.
Blood samples were collected. Biomarkers have been measured in BiomarCaRE Project and
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection in the MORGAM Project.
|
||||||||||
| KORA |
KORA Survey S3The cohort consists of the participants of representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort numbers 03 and 33 of the GER-AUG in the MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 55) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke or type 2 diabetes. Persons with history of myocardial infarction, stroke or hearth failure were excluded. See details in a MORGAM e-publication. Another case-cohort set (selection 42) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease or death during follow-up. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S3 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm).
The end of follow-up depends on when the person returned the follow-up questionnaire or when population registries gave information on vital status and address.
|
||||||||||
| KORA |
KORA Survey S4The cohort consists of the participants of representative population survey carried out as a part of the Cooperative Research in the study Region of Augsburg (KORA) S4 survey (Survey 2000).
The cohort is identified by Cohort numbers 24 and 34 of the GER-AUG in the MORGAM data, and it has one re-examination round after the baseline available. See the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 56) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke or type 2 diabetes. Persons with history of myocardial infarction, stroke or hearth failure were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S4 Baseline
Baseline examination (questionnaire and health examination). The main focus of this study is to assess health indicators (morbidity, mortality) and health care (utilization, costs), quantify prevalence of risk factors for cardiovascular and other chronic diseases, and study the impact of lifestyle, metabolic and genetic factors on cardiovascular and other chronic diseases.
Information on sociodemographic, risk factors (smoking, alcohol consumption, physical activity, etc.), medical history and family history of cardiovascular and other chronic diseases, medication use, and more was collected from standardized interviews.
A physical examination was performed.
Blood samples were collected. Biomarkers have been measured in BiomarCaRE Project in the MORGAM Project.
|
||||||||||
| KORA |
KORA Survey S4The cohort consists of the participants of representative population survey carried out as a part of the Cooperative Research in the study Region of Augsburg (KORA) S4 survey (Survey 2000).
The cohort is identified by Cohort numbers 24 and 34 of the GER-AUG in the MORGAM data, and it has one re-examination round after the baseline available. See the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 56) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke or type 2 diabetes. Persons with history of myocardial infarction, stroke or hearth failure were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S4 follow-up examination F4Re-examination (questionnaire and health examination) of the participants of the S4 survey. Information about diabetes, cardiovacular diseases and risk factors was collected. A physical examination was performed. Blood samples were collected. This re-examination data is identified by Round number 02 of the Cohorts 24 and 32 (GER-AUG) in the harmonized MORGAM data,
|
||||||||||
| KORA |
KORA Survey S4The cohort consists of the participants of representative population survey carried out as a part of the Cooperative Research in the study Region of Augsburg (KORA) S4 survey (Survey 2000).
The cohort is identified by Cohort numbers 24 and 34 of the GER-AUG in the MORGAM data, and it has one re-examination round after the baseline available. See the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 56) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke or type 2 diabetes. Persons with history of myocardial infarction, stroke or hearth failure were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
KORA S4 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/germany/ger-auga.htm).
The end of follow-up depends on when the person returned the follow-up questionnaire or when population registries gave information on vital status and address.
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 01 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 01 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 01 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/lithuania/ltu-kaua.htm). Follow-up for non-fatal events ends at the end of December 2016 with an upper age limit of 65 years for the follow-up of non-fatal stroke events.
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 02 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. See the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 02 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. See the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 02 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/lithuania/ltu-kaua.htm). Follow-up for non-fatal events ends at the end of December 2016 with an upper age limit of 65 years for the follow-up of non-fatal stroke events.
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 03 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. See the detailed cohort description in MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Kaunas |
Kaunas MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The cohort is identified by Cohort number 03 of the LTU-KAU in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. See the detailed cohort description in MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Kaunas MONICA Cohort 03 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/lithuania/ltu-kaua.htm). Follow-up for non-fatal events ends at the end of December 2016 with an upper age limit of 65 years for the follow-up of non-fatal stroke events.
|
||||||||||
| MATISS |
MATISS 1983-84 StudyThe cohort consists of the participants of a representative population survey carried out as a part of the so called MATISS (Malattie cardiovascolari ATerosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 21 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1983-84 Study Baseline
Data collected at baseline covered socio-demographic characteristics, lifestyle factors (smoking habit, alcohol consumption, diet, physical activity), and risk factors (blood pressure, heart rate, ECG read according to the Minnesota code, body mass index, total and HDL cholesterol, triglyceridemia, glycaemia, respiratory function).
|
||||||||||
| MATISS |
MATISS 1983-84 StudyThe cohort consists of the participants of a representative population survey carried out as a part of the so called MATISS (Malattie cardiovascolari ATerosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 21 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1983-83 Study Re-examinationRe-examination of the cohort (questionnaire and health examination). Data collected covered socio-demographic characteristics; lifestyle facrtors (smoking habit, alcohol consumption, diet, physical activity); and risk factors (blood pressure, heart rate, ECG read according to the Minnesota code, body mass index, total and HDL cholesterol, triglyceridemia, glycaemia, respiratory function); The examination of cognitive function and physical performance in people aged 65 years and older were performed. Biological samples (serum, plasma, buffy coat, emazie) were collected and stored in the biobank at the Istituto Superiore di Sanit? (ISS, National Institute of Health). Biomarkers in tha harmonized MORGAM data have been measured in the BiomarCaRE Project.
|
||||||||||
| MATISS |
MATISS 1983-84 StudyThe cohort consists of the participants of a representative population survey carried out as a part of the so called MATISS (Malattie cardiovascolari ATerosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 21 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1983-84 Study mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-roma.htm).
|
||||||||||
| MATISS |
MATISS 1986-87 StudyThe cohort consists of the participants of a fresh random sample in the representative population survey carried out as a part of the MATISS (Malattie cardiovascolari Aterosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 22 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1986-87 Study Baseline
Data collected at baseline covered socio-demographic characteristics, lifestyle factors (smoking habit, alcohol consumption, diet, physical activity), and risk factors (blood pressure, heart rate, ECG read according to the Minnesota code, body mass index, total and HDL cholesterol, triglyceridemia, glycaemia, respiratory function).
|
||||||||||
| MATISS |
MATISS 1986-87 StudyThe cohort consists of the participants of a fresh random sample in the representative population survey carried out as a part of the MATISS (Malattie cardiovascolari Aterosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 22 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1986-87 Study Re-examinationRe-examination of the cohort (questionnaire and health examination). Data collected covered socio-demographic characteristics; lifestyle facrtors (smoking habit, alcohol consumption, diet, physical activity); and risk factors (blood pressure, heart rate, ECG read according to the Minnesota code, body mass index, total and HDL cholesterol, triglyceridemia, glycaemia, respiratory function); The examination of cognitive function and physical performance in people aged 65 years and older were performed. Biological samples (serum, plasma, buffy coat, emazie) were collected and stored in the biobank at the Istituto Superiore di Sanit? (ISS, National Institute of Health). Biomarkers in tha harmonized MORGAM data have been measured in the BiomarCaRE Project.
|
||||||||||
| MATISS |
MATISS 1986-87 StudyThe cohort consists of the participants of a fresh random sample in the representative population survey carried out as a part of the MATISS (Malattie cardiovascolari Aterosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort has one re-examination round after the baseline. The cohort is identified by Cohort number 22 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1986-87 Study mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-roma.htm).
|
||||||||||
| MATISS |
MATISS 1993-96 StudyThe cohort consists of the participants of a fresh random sample in the representative population survey carried out as a part of the MATISS (Malattie cardiovascolari Aterosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort is identified by Cohort number 23 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1993-96 Study BaselineBaseline examination (questionnaire and health examination). Data collected covered socio-demographic characteristics; lifestyle facrtors (smoking habit, alcohol consumption, diet, physical activity); and risk factors (blood pressure, heart rate, ECG read according to the Minnesota code, body mass index, total and HDL cholesterol, triglyceridemia, glycaemia, respiratory function); The examination of cognitive function and physical performance in people aged 65 years and older were performed. Biological samples (serum, plasma, buffy coat, emazie) were collected and stored in the biobank at the Istituto Superiore di Sanit? (ISS, National Institute of Health). Biomarkers in the harmonized MORGAM data have been measured in the BiomarCaRE Project.
|
||||||||||
| MATISS |
MATISS 1993-96 StudyThe cohort consists of the participants of a fresh random sample in the representative population survey carried out as a part of the MATISS (Malattie cardiovascolari Aterosclerotiche, Istituto Superiore di Sanità) Project using the WHO MONICA methods. The cohort is identified by Cohort number 23 of the ITA-ROM in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
MATISS 1993-96 Study Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-roma.htm).
|
||||||||||
| Moli-sani |
Moli-sani Study cohortThe cohort consists of the participants of a representative population survey carried out as a part of the Moli-sani Study. Re-examination of the cohort has started in June 2015. The cohort is identified by Cohort number 21 of the ITA-MOL in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 61) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Moli-sani Study BaselineBaseline examination (questionnaire and health examination). Questions were asked on social status and childhood, physical activity, smoking habits, hormonal status in women, body weight history, inflammatory disease in the past year, antibiotics and influenza vaccine, hypertension, diabetes and dyslipidemia and relative dietary and pharmacological treatment, ischemic cardiovascular disease and relative treatment and possible hospitalization, pulmonary diseases, depressive status or anxiety with relative previous and current treatment, haematological disease, kidney disease, gastrointestinal disease, endocrinological disease, Alzheimer disease, tumours, surgical intervention and radiological tests in the past five years. All medication in the past 15 days were recorded. FFQ was used to determine daily nutritional intakes consumed in the past year. Blood pressure and anthropometric measurements were taken. Magnetic resonance imaging of brain was done for a sub-sample about 3,000 subjects. Electrocardiogram and spirometric tests were performed Biological samples were taken and stored. Citrated plasma, EDTA plasma, serum, cellular pellet and urinary spots are stored in liquid nitrogen in a specific Biobank Biomarkers have been measured in the BiomarCaRE Project.
|
||||||||||
| Moli-sani |
Moli-sani Study cohortThe cohort consists of the participants of a representative population survey carried out as a part of the Moli-sani Study. Re-examination of the cohort has started in June 2015. The cohort is identified by Cohort number 21 of the ITA-MOL in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 61) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure or atrial fibrillation were excluded. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Moli-sani Study Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events (includin heart failure and atrial fibrillation), type 2 diabetes, cancers, and death. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-mola.htm).
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the AUS-NEW in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination). Questionnaire contained questions on sociodemographic factor, smoking, alcohol, risk factors, and diseasea history.
Anthropometric measurements were taken, blood pressure was measured.
Fasting blood sample was taken.
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the AUS-NEW in MORGAM data, see the detailed cohort description in MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 01 mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths. See the end-points followed up at [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/australia/aus-newa.htm).
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the AUS-NEW in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination). Questionnaire contained questions on sociodemographic factor, smoking, alcohol, risk factors, and diseasea history.
Anthropometric measurements were taken, blood pressure was measured.
Blood sample was taken.
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the AUS-NEW in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 02 mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/australia/aus-newa.htm).
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the AUS-NEW in the MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination). Questionnaire contained questions on sociodemographic factor, smoking, alcohol, risk factors, and diseasea history.
Anthropometric measurements were taken, blood pressure was measured.
Blood sample was taken.
|
||||||||||
| Newcastle |
Newcastle MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the AUS-NEW in the MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Newcastle MONICA Cohort 03 mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/australia/aus-newa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1986The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 01 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 63) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1986 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1986The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 01 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 63) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Cohort 1986 Re-examination
Re-examination of the participants in the Northern Sweden Survey 1986. Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1986The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 01 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 63) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1986 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1990The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 02 of the SWE-NSW in the harmonized MORGAM data,, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1990 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1990The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 02 of the SWE-NSW in the harmonized MORGAM data,, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Cohort 1990 Re-examination
Re-examination of the participants in the Northern Sweden Survey 1990. Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1990The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 02 of the SWE-NSW in the harmonized MORGAM data,, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1990 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1994The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 03 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1994 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1994The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 03 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Cohort 1994 Re-examination
Re-examination of the participants in the Northern Sweden Survey 1994. Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1994The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project in Northern Sweden. The cohort has one re-examination round after the baseline.
The cohort is identified by Cohort number 03 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 62) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1994 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1999The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 24 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 63) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1999 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 1999The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 24 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 63) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, hearth failure, or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 1999 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 2004The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 25 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 2004 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
Baseline variables (from questionnaire and health examination). Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 2004The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 25 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 2004 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death for the harmonized MORGAM data, see the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 2009The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 26 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 2009 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 2009The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study.
The cohort is identified by Cohort number 26 of the SWE-NSW in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 2009 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death for the harmonized MORGAM data, see the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/sweden/swe-nswa.htm).
|
||||||||||
| NSW-MONICA |
Northern Sweden MONICA Survey 2014The cohort consists of the participants of a representative population survey carried out as a part of the Northern Sweden MONICA Study in 2014.
The cohort is identified by Cohort number 27 of the SWE-NSW in the harmonized MORGAM data. There is not yet disease follow-up available for this cohort in MORGAM Project. See the detailed cohort description in a MORGAM e-publication. There is no disease follow-up available for this cohort.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Northern Sweden MONICA Survey 2014 Baseline
Baseline variables (from questionnaire and health examination). Questionnaire contained questions on sociodemographic factors, health status, disease history, medication, smoking, and alcohol.
Anthropometric measures and blood pressure was measured. Also oral glucose tolerance test (OGTT) was done for the subsample (~60%).
Dietary data are collected and processed (for instance daily portion of different foods, grams / day of different foods, nutritional calculations, etc. are locally available).
Blood sample was taken. Biomarkers have been measured in the BiomarCaRE Project.
For the data available locally, please see the website of the study where the variable are described in detail. The questionnaire forms (basic and diet questionnaire) used are available in Swedish in the webpage of the study for download (basic: "Befolkningsundersökningsenkäter", diet: "Kostenkäter").
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 01 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/russia/rus-nova.htm). Follow-up for non-fatal events ends in the end of December 1998 with an upper age limit of 64 years for the follow-up of nonfatal coronary events and 74 years for the follow-up of stroke events.
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 02 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/russia/rus-nova.htm). Follow-up for non-fatal events ends in the end of December 1998 with an upper age limit of 64 years for the follow-up of nonfatal coronary events and 74 years for the follow-up of stroke events.
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Novosibirsk |
Novosibirsk MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk MONICA Cohort 03 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for the harmonized MORGAM data. See the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/russia/rus-nova.htm). Follow-up for non-fatal events ends in the end of December 1998 with an upper age limit of 64 years for the follow-up of nonfatal coronary events and 74 years for the follow-up of stroke events.
|
||||||||||
| Novosibirsk |
Novosibirsk Study 1983-85The cohort consists of the participants of a representative population survey using MONICA procedures. The cohort includes only men.
The cohort is identified by Cohort number 21 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk 1983-85 Survey Baseline
Baseline examination (questionnaire and health examination)
|
||||||||||
| Novosibirsk |
Novosibirsk Study 1983-85The cohort consists of the participants of a representative population survey using MONICA procedures. The cohort includes only men.
The cohort is identified by Cohort number 21 of the RUS-NOV in MORGAM data, see the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Novosibirsk 1983-85 Survey Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/russia/rus-nova.htm). Follow-up for non-fatal events ends in the end of December 1998 with an upper age limit of 64 years for the follow-up of nonfatal coronary events and 74 years for the follow-up of stroke events.
|
||||||||||
| PAMELA |
PAMELA StudyThe cohort consists of the participants of a representative population survey carried out using the MONICA procedures.
The cohort is identified by Cohort number 21 of the ITA-PAM in the MORGAM data, see the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-pama.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PAMELA Study Baseline
Baseline examination (questionnaire and health examination).
Cigarette smoking was evaluated from the medical history. Psychologic variables were collected by the questionnaire.
Clinical, home and ambulatory blood pressure measurements, echocardiographic assessment of cardiac structure and function (left ventricular mass) as well as laboratory examinations (glucose and lipids) and anthropometric measures were taken. Personal and family histories were collected.
Blood samples were taken.
|
||||||||||
| PAMELA |
PAMELA StudyThe cohort consists of the participants of a representative population survey carried out using the MONICA procedures.
The cohort is identified by Cohort number 21 of the ITA-PAM in the MORGAM data, see the detailed cohort description in [the MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-pama.htm).
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PAMELA Study Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death for the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/italy/ita-PAMa.htm).
|
||||||||||
| PRIME |
PRIME BelfastThe cohort was recruited to broadly match the social class structure of the background population in Belfast, Nothern Ireland, UK as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the UNK-BEL in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 39) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Belfast Baseline
Baseline examination (questionnaire and health examination)
Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project.
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection.
|
||||||||||
| PRIME |
PRIME BelfastThe cohort was recruited to broadly match the social class structure of the background population in Belfast, Nothern Ireland, UK as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the UNK-BEL in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 39) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Belfast Mortality and disease outcome follow-up in MORGAM dataFollow-up for cardiovascular events, type 2 diabetes, cancers and death. See the end-points followed up in MORGAM e-publication. Follow-up ends 18 years after the baseline examination of each person.
|
||||||||||
| PRIME |
PRIME LilleThe cohort was recruited to broadly match the social class structure of the background population in Lille, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-LIL in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 32) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Lille BaselineBaseline examination (questionnaire and health examination) Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection.
|
||||||||||
| PRIME |
PRIME LilleThe cohort was recruited to broadly match the social class structure of the background population in Lille, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-LIL in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 32) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Lille Mortality and disease outcome follow-up in MORGAM dataFollow-up for cardiovascular events and death. See the end-points followed up in the MORGAM e-publication. Follow-up ends 10 years after the baseline examination of each person.
|
||||||||||
| PRIME |
PRIME StrasbourgThe cohort was recruited to broadly match the social class structure of the background population in Strasbourg, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-STR in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 34) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Strasbourg BaselineBaseline examination (questionnaire and health examination) Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection.
|
||||||||||
| PRIME |
PRIME StrasbourgThe cohort was recruited to broadly match the social class structure of the background population in Strasbourg, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-STR in the harmonized MORGAM data, see the detailed cohort description in a MORGAM e-publication. A case-cohort set (selection 34) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Strasbourg Mortality and disease outcome follow-up in MORGAM dataFollow-up for cardiovascular events and death. See the end-points followed up in MORGAM e-publication. Follow-up ends 10 years after the baseline examination of each person.
|
||||||||||
| PRIME |
PRIME ToulouseThe cohort was recruited to broadly match the social class structure of the background population in Toulouse, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-TOU in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 33) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Toulouse Baseline
Baseline examination (questionnaire and health examination)
Metabochip and Exome+ genotyping (GWA studies) has been done for the case-cohort selection.
|
||||||||||
| PRIME |
PRIME ToulouseThe cohort was recruited to broadly match the social class structure of the background population in Toulouse, France as a part of the PRIME Study. The cohort includes only men. The cohort is identified by Cohort number 21 of the FRA-TOU in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 33) was sampled from the participants of this cohort for MORGAM's Genetic SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of hard coronary heart disease, stroke or death during follow-up and subjects with documented history of myocardial infarction or stroke at baseline. See details in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
PRIME Toulouse Mortality and disease outcome follow-up in MORGAM dataFollow-up for cardiovascular events and death. See the end-points followed up in MORGAM e-publication. Follow-up ends 10 years after the baseline examination of each person.
|
||||||||||
| SHHEC |
Scottish Heart Health Study 1984-87The cohort consists of the participants of a representative population survey carried out in the Scottish Heart Health Study.
The cohort is identified by Cohort number 01 of the UNK-SHH (RU=03) in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 54) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Scottish Heart Health Study 1984-87 Baseline
Baseline examination (questionnaire and health examination). The questionnaire included a personal health record for self completion, including several cardiovascular questions,a food frequency questionnaire, and the Bortner questionnaire for type A personality.
Participants were weighed, and their height measured. Blood pressure was measured twice. A 12 lead electrocardiogram was recorded and expired air carbon monoxide measured.
A blood sample was taken and a subcutaneous fat biopsy were performed. 24 hour urine collectio was performed.
Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project.
|
||||||||||
| SHHEC |
Scottish Heart Health Study 1984-87The cohort consists of the participants of a representative population survey carried out in the Scottish Heart Health Study.
The cohort is identified by Cohort number 01 of the UNK-SHH (RU=03) in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 54) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Scottish Heart Health Study 1984-87 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death for the harmonized MORGAM data. See the end-points followed up in the [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/uk/unk-sco.htm).
|
||||||||||
| SHHEC |
First Scottish MONICA Survey 1986The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the UNK-EDI/GLA (RU=01 & 02) in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selections 49 and 50) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
First Scottish MONICA Survey Baseline
Baseline examination (questionnaire and health examination). The questionnaire included a personal health record for self completion, including several cardiovascular questions,a food frequency questionnaire, and the Bortner questionnaire for type A personality.
Participants were weighed, and their height measured. Blood pressure was measured twice. A 12 lead electrocardiogram was recorded and expired air carbon monoxide measured.
A blood sample was taken and a subcutaneous fat biopsy were performed. 24 hour urine collectio was performed.
Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project.
|
||||||||||
| SHHEC |
First Scottish MONICA Survey 1986The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the UNK-EDI/GLA (RU=01 & 02) in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selections 49 and 50) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
First Scottish MONICA Survey Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/uk/unk-sco.htm).
|
||||||||||
| SHHEC |
Third Scottish MONICA Survey 1992The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the UNK-GLA in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 51) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Third Scottish MONICA Survey Baseline
Baseline examination (questionnaire and health examination). Participants completed a self-administered personal health record and a food frequency questionnaire (FFQ). The personal health questionnaire included information on educational level, employment status, and smoking habits.
Anthropometric measurements were measured. Blood pressure was measured twice.
A blood sample was taken.
Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project.
|
||||||||||
| SHHEC |
Third Scottish MONICA Survey 1992The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the UNK-GLA in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 51) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Third Scottish MONICA Survey Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death or the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/uk/unk-sco.htm).
|
||||||||||
| SHHEC |
Fourth Scottish MONICA Survey 1995The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the UNK-GLA in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 52) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Fourth Scottish MONICA Survey Baseline
Baseline examination (questionnaire and health examination). Participants completed a self-administered personal health record and a food frequency questionnaire (FFQ). The personal health questionnaire included information on educational level, employment status, and smoking habits.
Anthropometric measurements were measured. Blood pressure was measured twice.
A blood sample was taken.
Biomarkers have been measured in the MORGAM Biomarker SubStudy and the BiomarCaRE Project.
|
||||||||||
| SHHEC |
Fourth Scottish MONICA Survey 1995The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the UNK-GLA in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 52) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Fourth Scottish MONICA Survey Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death for the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/uk/unk-sco.htm).
|
||||||||||
| SHHEC |
Second Scottish MONICA Survey 1989The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 21 of the UNK-GLA in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 53) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Second Scottish MONICA Survey Baseline
Baseline examination (questionnaire and health examination). Participants completed a self-administered personal health record and a food frequency questionnaire
(FFQ). The personal health questionnaire included information on educational level, employment status, and smoking habits.
Anthropometric measurements were measured. Blood pressure was measured twice.
A blood sample was taken.
Biomarkers have been measured in MORGAM Biomarker SubStudy and the BiomarCaRE Project.
|
||||||||||
| SHHEC |
Second Scottish MONICA Survey 1989The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 21 of the UNK-GLA in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication. A case-cohort set (selection 53) was sampled from the participants of this cohort for MORGAM's Biomarker SubStudy. The case-cohort set consists of a random subsample of the cohort and all cases of incident myocardial infarction, unstable angina pectoris, stroke, heart failure, atrial fibrillation or type 2 diabetes. Persons with history of myocardial infarction, stroke, heart failure or atrial fibrillation were excluded. See details in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Second Scottish MONICA Survey Mmortality and disease outcome follow-up in MORAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death for the harmonized MORGAM data. See the end-points followed up in [MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/uk/unk-sco.htm).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in the MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 01 Mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-tara.htm).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 02 Mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-tara.htm).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Tarnobrzeg |
Tarnobrzeg MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the POL-TAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tarnobrzeg MONICA Cohort 03 Mortality and disease outcome follow-up in MORGAM data
Follow-up for fatal cardiovascular events and deaths in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-tara.htm).
|
||||||||||
| Tromso |
Tromsø Survey 3The cohort consists of the participants of the third Tromsø Study. Many of the participants are also included in the previous or later surveys.
The participants of the Survey 3 are identified by Cohort number 21 and examination round 03 of the NOR-TRO in the harmonized MORGAM data. The third survey is the first Tromsø survey included in the MORGAM data. In MORGAM data, the age group included is 19-62 years. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tromso Survey 3
Baseline examination (questionnaire and health examination).
A brief questionnaire accompanied the invitation included questions on diagnosed cardiovascular diseases or diabetes, symptoms of cardiovascular diseases, consumption of salty food and preference of fat type, smoking habits, coffee consumption and physical activity during work and leisure time. People who attended the study received another questionnaire on diet, psychological pressure, ?stress?, social conditions, the occurrence of disease in relatives, pregnancy, birth and menstruation and the public use of medical health services.
Measurements of height, weight and blood pressure were taken. A blood sample was also taken to measure serum total cholesterol, HDL cholesterol, triglycerides and gamma-glutamyltransferase (gamma-GT). A simple electrocardiogram (ECG) was also taken.
Women aged 40-56 years were offered a breast cancer examination (X-ray mammography).
The survey 3 is included in the harmonized MORGAM data. This data collection event is identified by the round number 03 of the NOR-TRO Cohort 21 in the MORGAM data.
Local data available from questionnaires, various measurements and clinical examinations from all Tromsø surveys are described in detail in the page http://tromsoundersokelsen.uit.no/tromso/. The questionnaire forms and invitation letter used are available in the webpage of the study for download.
|
||||||||||
| Tromso |
Tromsø Survey 4The cohort consits of the participants of the fourth Tromsø Study. Many of the participants participated also in the previous or later surveys, and therefore they can be also members of the Tromsø Surveys 1-7. The participants of the survey were also invited to re-examinations in the later surveys
The participants of the Survey 4 are identified by Cohort number 21 and examination round 04 of the NOR-TRO in the harmonized MORGAM data (those examined first time in the fourth study have entry number 04). See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tromso Survey 4
Baseline examination (questionnaire and health examination).
A brief questionnaire accompanied the invitation including the questions on general health condition, diagnosed heart and cardiovascular diseases or diabetes and history of heart and family cardiovascular diseases, muscle pains and physical discomfort, passive smoking and smoking habits, physical leisure activity, coffee, alcohol and fat consumption, education level and current work situation. People who attended the study received another questionnaire on illnesses, social conditions, use of health services, diet, alcohol, menstruation, pregnancy and contraception. Separate questionnaires were prepared for people aged under 70 and for those aged 70 or elder.
Measurements of height, weight and blood pressure were taken. A blood sample was also taken to measure serum total cholesterol, HDL cholesterol, triglycerides, gamma-glutamyltransferase (GT), haemoglobin and blood cell count ("plot").
Everyone in the 55-74 age group, along with 5-10 percent in the 25-54 and 75-85 age groups were given the opportunity to undergo an extensive special study (second visit 2-4 weeks later). A total of 7965 people accepted this offer. This included also measurement of bone density as a part of the TROST study. The second visit included ultrasound of carotid artery and abdominal aorta, echocardiography, electrocardiography, bone densitometry of the hip (dual-energy X-ray absorptiometry, DEXA) and spirometry.
The survey 4 is included in the harmonized MORGAM data. This data collection event is identified by the round number 04 of the NOR-TRO Cohort 21 in the MORGAM data.
Local data available from questionnaires, various measurements and clinical examinations from all Tromsø surveys are described in detail in the page http://tromsoundersokelsen.uit.no/tromso/. The questionnaire forms and invitation letter used are available in the webpage of the study for download.
|
||||||||||
| Tromso |
Tromsø Survey 3The cohort consists of the participants of the third Tromsø Study. Many of the participants are also included in the previous or later surveys.
The participants of the Survey 3 are identified by Cohort number 21 and examination round 03 of the NOR-TRO in the harmonized MORGAM data. The third survey is the first Tromsø survey included in the MORGAM data. In MORGAM data, the age group included is 19-62 years. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tromso 3 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/norway/nor-troa.htm).
Specific disease endpoint data are available in subsamples.
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 01 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 01 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 01 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-wara.htm). Follow-up for non-fatal events ends in the end of December 1994 with upper age limit of 64 years.
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 02 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 02The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 02 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 02 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-wara.htm). Follow-up for non-fatal events ends in the end of December 1994 with upper age limit of 64 years.
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 03 Baseline
Baseline examination (questionnaire and health examination).
|
||||||||||
| Warsaw |
Warsaw MONICA Study Cohort 03The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project.
The cohort is identified by Cohort number 03 of the POL-WAR in the harmonized MORGAM data. See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Warsaw MONICA Cohort 03 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/poland/pol-wara.htm). Follow-up for non-fatal events ends in the end of December 1994 with upper age limit of 64 years.
|
||||||||||
| Latina |
Latina MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The survivors of the cohort members in the province of Latina were invited to the rewiew study in the Oec survey in 1998-2002. The cohort is identified by Cohort number 01 of the ITA-ROM in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Latina MONICA Study Cohort 01 Baseline
Baseline examination (questionnaire and health examination). Data collected on socio-demographic characteristics; lifestyles (smoking habit); risk factors (blood pressure, body mass index, total and HDL cholesterol, thiocyanatemia).
|
||||||||||
| Latina |
Latina MONICA Study Cohort 01The cohort consists of the participants of a representative population survey carried out as a part of the WHO MONICA Project. The survivors of the cohort members in the province of Latina were invited to the rewiew study in the Oec survey in 1998-2002. The cohort is identified by Cohort number 01 of the ITA-ROM in the harmonized MORGAM data, see the detailed cohort description in the MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Latina MONICA Study Cohort 01 mortality and disease outcome follow-up in MORGAM dataFollow-up for cardiovascular events and death. See the end-points followed up in MORGAM e-publication.
|
||||||||||
| FINRISK |
FINRISK Survey 2007The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 2007. The cohort is identified by Cohort number 26 of the FIN-EAS/WES in the harmonized MORGAM data (and also few people in round 06 of Cohort 01, round 05 of Cohort 02, round 04 of Cohort 03, round 03 of Cohort 24, and round 02 of Cohort 25). See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 2007 baselineData was collected from each participant at baseline via questionnaire and health examination. The baseline data includes background information on socioeconomic status, smoking, diet, as well as information from the health examination, such as blood pressure, height and weight. Blood samples were collected during the health examination. For the data available locally, please see the webpage of the THL Biobank where the local variables are described in detail. The questionnaire forms used in the survey are available for download in the webpage of the THL. The description of the FINRISK 2007 study and the local variables available are described in the Finnish Data Resources Catalogue (mainly in Finnish). The baseline data for the participants in 2007 are identified by Round 06 of the Cohort 01, Round 05 of the Cohort 02, Round 04 of the Cohort 03, Round 01 of the Cohort 24, Round 02 of the Cohort 25 and Round 01 of the Cohort 26 (FIN-EAS/WES) in the harmonized MORGAM data.
|
||||||||||
| FINRISK |
FINRISK Survey 2007The cohort consists of the participants of a representative population survey carried out as a part of the national FINRISK Study in 2007. The cohort is identified by Cohort number 26 of the FIN-EAS/WES in the harmonized MORGAM data (and also few people in round 06 of Cohort 01, round 05 of Cohort 02, round 04 of Cohort 03, round 03 of Cohort 24, and round 02 of Cohort 25). See the detailed cohort description in a MORGAM e-publication. Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
FINRISK 2007 mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events, type 2 diabetes, cancers and death in the harmonized MORGAM data, see the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/finland/fin-fina.htm).
For the data available locally (registries, nutrition, genomics, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/the-national-finrisk-study-1992-2012) where the variables are listed in more detail. The data of national health registers (e.g., mortality, cancer, health care and medicines) are available by request through the Findata-process.
|
||||||||||
| Tromso |
Tromsø Survey 4The cohort consits of the participants of the fourth Tromsø Study. Many of the participants participated also in the previous or later surveys, and therefore they can be also members of the Tromsø Surveys 1-7. The participants of the survey were also invited to re-examinations in the later surveys
The participants of the Survey 4 are identified by Cohort number 21 and examination round 04 of the NOR-TRO in the harmonized MORGAM data (those examined first time in the fourth study have entry number 04). See the detailed cohort description in a MORGAM e-publication.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Tromso 4 Mortality and disease outcome follow-up in MORGAM data
Follow-up for cardiovascular events and death in the harmonized MORGAM data. See the end-points followed up in [a MORGAM e-publication](https://www.thl.fi/publications/morgam/cohorts/full/norway/nor-troa.htm).
Specific disease endpoint data are available in subsamples.
|
||||||||||
| Health2000/2011 |
Health 2000/2011 CohortThe cohort consists of the participants of a representative population survey carried out as a part of the national Health 2000 Survey that was re-examined in the Health 2011 Survey with a new random sample of persons aged 18-28 years.
The cohort is identified by Cohort number 21 of the FIN-H2K in the harmonized MORGAM data.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Health 2000 Survey
Baseline examination (questionnaire and health examination). People aged 18-29 only participated in the interview and filled out a basic questionnaire. The main content covered in the questionnaire were functional capacity, quality of life and income, common symptoms, weight and height, time use and leisure activities, physical exercise, alcohol use, health promotion, living environment, psychological experiences, mood and feelings, as well as job perception and job strain.
The interview on mental health disorders or symptoms focused on four principal categories: mood disorders, substance addiction, psychoses and anxiety disorders. The participants were asked to describe their ordinary diet over the past 12 months in the dietary questionnaire (semi-quantitative FFQ).
In the health examination blood pressure and heart rate were measured and rest ECG recorded, basic anthropometric measurements were taken, including height, body circumference measurements and sagittal body measure. Spirometry was taken and bioimpedance was measured. The health examination included a clinical and radiographic examination of the mouth.
For the measurement of functional capacity, tests were carried out on eyesight and hearing, cognitive functioning, balance, perceptual-motor speed and hand grip strength.
Ultrasound examination of calcaneal bone was performed.
Samples of whole blood, serum, lithium heparin plasma and spot urine were collected from all subjects, faeces and saliva samples were obtained from a subsample of subjects.
Imputed genotype data, chip genotypes, telomeres and metabolomics are available.
This data collection event is identified by the round number 01 of the FIN-H2K Cohort 21 in the harmonized MORGAM data.
For the data available locally, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/health-2000-and-2011-surveys) where the local variables are described in detail. The questionnaire forms used are available in the [webpage of the THL](https://thl.fi/en/web/thlfi-en/research-and-development/research-and-projects/health-2000-2011/forms/health-2000-forms) for download.
|
||||||||||
| Health2000/2011 |
Health 2000/2011 CohortThe cohort consists of the participants of a representative population survey carried out as a part of the national Health 2000 Survey that was re-examined in the Health 2011 Survey with a new random sample of persons aged 18-28 years.
The cohort is identified by Cohort number 21 of the FIN-H2K in the harmonized MORGAM data.
Selection Criteria
Recruitment
Number of participants
Files
No files could be found.
|
Health 2011 Survey
Re-examination of the H2000 cohort (questionnaire and health examination). The content covered in the questionnaire were sociodemographic factors, financial situation, living and working conditions, work ability, functional capacity, quality of life, common symptoms, weight and height, lifestyle, time use and leisure activities, physical exercise, alcohol use, health promotion, psychological experiences, mood and feelings, as well as job perception and job strain.
The interview on mental health disorders or symptoms focused on depressive, anxiety and alcohol use disorders and psychotic symptoms. There were several questions on dietary habits in the interview.
In the health examination blood pressure and heart rate were measured and resting ECG recorded, basic anthropometric measurements were taken, including weight, height, and body circumference measurements. Spirometry was taken and bioimpedance was measured. The clinical oral health examinations were carried out in two out of the five field examination areas.
Several performance tests measuring mobility, strength, balance and joint functions were conducted.
Samples of whole blood, serum, lithium heparin plasma and EDTA plasma were collected from all participants. DNA was collected in the substudy.
Imputed genotype data, chip genotypes, and metabolomics are available.
This data collection event is identified by the round number 02 of the FIN-H2K Cohort 21 in the harmonized MORGAM data. Those participants that were examined first time in 2011 have the entry number 02.
For the data available locally, please see the [website of THL Biobank](https://thl.fi/en/web/thl-biobank/for-researchers/sample-collections/health-2000-and-2011-surveys) where the local variables are described in detail. The questionnaire forms used are available in the [webpage of the THL](https://thl.fi/en/web/thlfi-en/research-and-development/research-and-projects/health-2000-2011/forms/health-2011-forms) for download.
|
Harmonization
- Complete - study-specific variable is the same as DataSchema variable (status = identical) or needs transformation to generate DataSchema variable (status = compatible)
- Impossible - study does not collect DataSchema variable (status = unavailable) or cannot be used to generate DataSchema variable (status = incompatible)
- Undetermined - harmonization status not determined
- Not Applicable - harmonization status is not relevant
Files
| # | Name | Description | Size | Actions |
|---|---|---|---|---|
No files could be found.
Variables Classifications
No coverage data about the variables classifications are available.